The site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Expression of cell surface CD124 by B220-positve and -negative splenic lymphocytes from C57BL/6 mice. Spleen cells from C57BL/6 mice were treated with ACK lysis buffer, washed, and were labeled with purified Fc Block (Cat. No. 553142) to block mouse Fc receptors. The cells were then stained with PE Rat Anti-Mouse CD124 (Cat. No 561695; 0.25 µg/10e6 cells) and FITC Rat Anti-Mouse CD45R/B220 (0.06 µg; Cat. No. 553088) and were analyzed by two-color flow cytometry. The levels of CD124 expressed by B220-positive and B220-negative cells (with the light-scattering characteristics of viable lymphocytes) are shown in the two-color dot plot (right panel). Staining with the PE-mIL4R-M1 antibody (right panel) is compared to staining derived with a PE Rat IgG2a, κ Isotype Control antibody (0.25 µg, Cat. No. 553930) that is shown in left panel.
Expression of cell surface CD124 by B220-positve and -negative splenic lymphocytes from C57BL/6 mice. Spleen cells from C57BL/6 mice were treated with ACK lysis buffer, washed, and were labeled with purified Fc Block (Cat. No. 553142) to block mouse Fc receptors. The cells were then stained with PE Rat Anti-Mouse CD124 (Cat. No 561695; 0.25 µg/10e6 cells) and FITC Rat Anti-Mouse CD45R/B220 (0.06 µg; Cat. No. 553088) and were analyzed by two-color flow cytometry. The levels of CD124 expressed by B220-positive and B220-negative cells (with the light-scattering characteristics of viable lymphocytes) are shown in the two-color dot plot (right panel). Staining with the PE-mIL4R-M1 antibody (right panel) is compared to staining derived with a PE Rat IgG2a, κ Isotype Control antibody (0.25 µg, Cat. No. 553930) that is shown in left panel.
Expression of cell surface CD124 by B220-positve and -negative splenic lymphocytes from C57BL/6 mice. Spleen cells from C57BL/6 mice were treated with ACK lysis buffer, washed, and were labeled with purified Fc Block (Cat. No. 553142) to block mouse Fc receptors. The cells were then stained with PE Rat Anti-Mouse CD124 (Cat. No 561695; 0.25 µg/10e6 cells) and FITC Rat Anti-Mouse CD45R/B220 (0.06 µg; Cat. No. 553088) and were analyzed by two-color flow cytometry. The levels of CD124 expressed by B220-positive and B220-negative cells (with the light-scattering characteristics of viable lymphocytes) are shown in the two-color dot plot (right panel). Staining with the PE-mIL4R-M1 antibody (right panel) is compared to staining derived with a PE Rat IgG2a, κ Isotype Control antibody (0.25 µg, Cat. No. 553930) that is shown in left panel.
Expression of cell surface CD124 by B220-positve and -negative splenic lymphocytes from C57BL/6 mice. Spleen cells from C57BL/6 mice were treated with ACK lysis buffer, washed, and were labeled with purified Fc Block (Cat. No. 553142) to block mouse Fc receptors. The cells were then stained with PE Rat Anti-Mouse CD124 (Cat. No 561695; 0.25 µg/10e6 cells) and FITC Rat Anti-Mouse CD45R/B220 (0.06 µg; Cat. No. 553088) and were analyzed by two-color flow cytometry. The levels of CD124 expressed by B220-positive and B220-negative cells (with the light-scattering characteristics of viable lymphocytes) are shown in the two-color dot plot (right panel). Staining with the PE-mIL4R-M1 antibody (right panel) is compared to staining derived with a PE Rat IgG2a, κ Isotype Control antibody (0.25 µg, Cat. No. 553930) that is shown in left panel.
Expression of cell surface CD124 by B220-positve and -negative splenic lymphocytes from C57BL/6 mice. Spleen cells from C57BL/6 mice were treated with ACK lysis buffer, washed, and were labeled with purified Fc Block (Cat. No. 553142) to block mouse Fc receptors. The cells were then stained with PE Rat Anti-Mouse CD124 (Cat. No 561695; 0.25 µg/10e6 cells) and FITC Rat Anti-Mouse CD45R/B220 (0.06 µg; Cat. No. 553088) and were analyzed by two-color flow cytometry. The levels of CD124 expressed by B220-positive and B220-negative cells (with the light-scattering characteristics of viable lymphocytes) are shown in the two-color dot plot (right panel). Staining with the PE-mIL4R-M1 antibody (right panel) is compared to staining derived with a PE Rat IgG2a, κ Isotype Control antibody (0.25 µg, Cat. No. 553930) that is shown in left panel.
Expression of cell surface CD124 by B220-positve and -negative splenic lymphocytes from C57BL/6 mice. Spleen cells from C57BL/6 mice were treated with ACK lysis buffer, washed, and were labeled with purified Fc Block (Cat. No. 553142) to block mouse Fc receptors. The cells were then stained with PE Rat Anti-Mouse CD124 (Cat. No 561695; 0.25 µg/10e6 cells) and FITC Rat Anti-Mouse CD45R/B220 (0.06 µg; Cat. No. 553088) and were analyzed by two-color flow cytometry. The levels of CD124 expressed by B220-positive and B220-negative cells (with the light-scattering characteristics of viable lymphocytes) are shown in the two-color dot plot (right panel). Staining with the PE-mIL4R-M1 antibody (right panel) is compared to staining derived with a PE Rat IgG2a, κ Isotype Control antibody (0.25 µg, Cat. No. 553930) that is shown in left panel.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Immunofluorescent staining and Flow Cytometric Analysis: The PE conjugated form of the mIL4R-M1 antibody can be used for the immunofluorescent staining and flow cytometric analysis of nucleated mouse cells to measure their expressed levels of surface CD124. An appropriate PE Ig isotype control is clone R35-95 (Cat. No. 553930).
ELISA: The biotinylated mIL4R-M1 (Cat. No. 552508) antibody is useful as a detection antibody in a sandwich ELISA that measures soluble mouse CD124 protein levels. The mIL-4R-M1 antibody can be paired with the mIL4R-M2 antibody, Cat. No. 552952, and recombinant soluble mIL-4Rα as the standard.
Neutralization: The mIL4R-M1 antibody reportedly blocks IL-4 binding to and biological effects on, IL-4R-positive cells. Note: For use in in vivo and in vitro applications, our NA/LE format (no azide/ low endotoxin), Cat. No. 552288, is recommended.
Immunoprecipitation: The mIL4R-M1 antibody is reported to immunoprecipitate mouse CD124 proteins. Please note that this application is not routinely tested at BD Biosciences Pharmingen.
The mIL4R-M1 monoclonal antibody specifically binds to CD124 which is also known as the α subunit of the mouse Interleukin-4 Receptor (IL-4Rα). The mouse IL-4Rα is a 140 kDa transmembrane glycoprotein that is expressed by B and T lymphocytes and a variety of other hematopoietic and nonhematopoietic cells and cell lines. The cell surface IL-4Rα chain binds IL-4 with high affinity and associates with either the common γ chain (IL-4Rα/γc; aka, type I IL-4R) or the IL-13 receptor alpha subunit (IL-4Rα/IL-13Rα; aka, type II IL-4R complex) to form two distinct types of signal-transducing IL-4R complexes. The type I IL-4 receptor complex specifically binds IL-4 whereas the type II IL-4R binds and transduces signals from either IL-4 or IL-13. The mIL4R-M1 antibody blocks IL-4 binding to cells and is reported to be a potent inhibitor of IL-4's biological activities. The mIL4R-M1 antibody also recognizes naturally-occurring, soluble truncated forms of IL-4Rα (sIL-4R) that result either from enzymatic cleavage of the cell surface extracellular IL-4Rα domain or from differential mRNAsplicing and secretion by cells. These sIL-4R retain their high-affinity ligand binding domain and appear to either enhance or inhibit IL-4-mediated functions depending on the relative local levels of IL-4 and sIL-4R.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.